Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Ambu A-S expects increase in revenue and profit in latest quarter

Ambu A-S will release its quarterly results on 5 November 2026. Two analysts on average expect earnings per share of 0.862 DKK, up from 0.430 DKK in the year-ago quarter. Six analysts forecast revenue to rise 13.54 percent to around 1.66 billion DKK. For the past fiscal year, the analyst consensus is 2.40 DKK earnings per share and revenue of 6.44 billion DKK. » More on finanzen.net
Ambu share falls 15% after slightly missed quarter

Ambu narrowly missed consensus expectations in the third quarter with EPS of $0.62 and revenue of $1.64bn, after which the stock fell 15.15% to $66.35. Organic revenue growth was 10.3%, driven by Endoscopy Solutions (+16%), and reported EBIT rose to 13.5%. Management raised the full-year forecast for organic growth to around 10% but warned of short-term margin pressures from higher selling expenses, currency and duties costs, and upcoming duty refunds that are expected to support the next quarter. » More on de.investing.com
Ambu forecasts significant quarterly growth in EPS and revenue

Ambu will publish results on 26 August 2026 for the quarter ended 30 June 2026. Analysts on average expect EPS of 0.617 DKK, up 34.13% from 0.460 DKK a year earlier, and revenue of 1.65 billion DKK on average (+9.43% versus 1.51 billion DKK). For the current fiscal year, consensus estimates are 2.32 DKK earnings per share (previous year 2.29 DKK) and annual revenue of 6.47 billion DKK (previous year 6.04 billion DKK). » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2025, Ambu has already paid €0.0549 in dividends. The last payout was in December 2025.

Financials

In the last quarter, Ambu had revenue of €218.63M and net profit of €20.8M

(EUR)	June 2026	YoY
Revenue	218.63M	8.24%
Gross profit	129.98M	9.33%
Net profit	20.8M	26.14%
EBITDA	42.79M	20.02%

Fundamentals

Metric	Value
Market capitalization	€2.49B
Number of shares	232.24M
52-week high/low	€13.75 - €8.39
Dividend yield	0.52%
Dividends TTM	€0.0549
Beta	1.32
P/E ratio	42.51
PEG ratio	1.00
P/B ratio	3.51
P/S ratio	3.02

Company profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, head immobilizers, CPR breathing barriers, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Name	Ambu
CEO	Britt Meelby Jensen
Headquarters	Ballerup, cr Denmark
Website	ambu.com
Sector	Health Care
Industry	Health Care Equipment & Supplies
IPO	02/11/2004
Employees	5,384